Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
NOC/c box without indication
-
Hi, I understand that NOC/c product materials have to have the text "PRODUCT has been issued conditional marketing authorization pending the results of studies to verify its clinical benefit. Patients should be advised of this conditional marketing authorization."
My question is- does this text always have to be accompanied by the indication or can there be PAAB exempt pieces where only this text is there and no indication? Thanks! -
Hi @gbrl88
The NOC/C box should be accompanied by the full indication as per the respective product monograph. Please see our guidance document regarding NOC/C requirements in advertising, Guidance on Advertising for Drugs with Notice of Compliance with Conditions NOC/c. Please also see PAAB Q&A 619 regarding potential exempt messages with an NOC/C product.
